Related Experiment Video
Updated: Apr 30, 2026
08:04
Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
18.6K
Rapamycin and dietary restriction induce metabolically distinctive changes in mouse liver
Zhen Yu1, Rong Wang1, Wilson C Fok2
1Linus Pauling Institute, Oregon State University, Corvallis.
Summary
Dietary restriction and rapamycin both inhibit fat production but only dietary restriction promotes fatty acid breakdown for energy. This highlights key metabolic differences between these anti-aging interventions.
Area of Science:
- Gerontology
- Metabolic pathways
- Aging research
Background:
- Dietary restriction (DR) is a proven method to delay aging.
- DR mimetics are sought to replicate its benefits.
- Rapamycin, a mTOR pathway activator, extends lifespan in mice but causes insulin resistance.
Purpose of the Study:
- To investigate the mechanisms behind rapamycin-induced insulin resistance.
- To compare the liver metabolic effects of DR and rapamycin.
Main Methods:
- Mice were treated with either DR or rapamycin for 6 months.
- Liver metabolism, including lipogenesis, lipolysis, fatty acid oxidation, and ketone body production, was analyzed.
Main Results:
- Both DR and rapamycin inhibited lipogenesis and activated lipolysis, increasing nonesterified fatty acids.
- Only DR significantly increased beta-oxidation of fatty acids.
- DR treatment led to increased ketone body production, unlike rapamycin treatment.
Conclusions:
- DR and rapamycin exhibit distinct effects on liver fatty acid metabolism.
- DR promotes complete fatty acid oxidation and ketone body production, potentially explaining its health benefits without insulin resistance.
- Understanding these differences is crucial for developing safe and effective DR mimetics.
